PlainRecalls
FDA Food Moderate Class II Completed

Douglas Labs Stress-B-Plus Dietary Supplement, Tablets, 90 tablets per bottle. UPC # 10539 97452, Lot Numbers ,50335944 and 50344396. Expiration Date 04/11/2026

Reported: November 27, 2024 Initiated: October 7, 2024 #F-0139-2025

Product Description

Douglas Labs Stress-B-Plus Dietary Supplement, Tablets, 90 tablets per bottle. UPC # 10539 97452, Lot Numbers ,50335944 and 50344396. Expiration Date 04/11/2026

Reason for Recall

Nestle Health Science (NHS U.S., LLC) is initiating a recall of Douglas Labs Stress-B-Plus Dietary Supplement Tablets, 90 tablets per bottle. The bottle is white and made of plastic. Lot Numbers 50335944,50344396, expiration date 04/11/2026. The product is being recalled because of Incorrect formulation manufactured vs label claims. Product was manufactured with Niacin (as Nicotinic acid) and supplement facts panel states contains Niacin (as Niacinamide).

Details

Units Affected
3,269 bottles in market
Distribution
AK,AZ,CA,CO,DE,FL,GA,IA,ID,IL,IN,KS,KY,LA,MA,MD,MI,MN,MO,NC,NH,NJ,NM,NY,OH,OK,OR,PA,SD,TN,TX,VA,WA,WI,WV
Location
Bridgewater, NJ

Frequently Asked Questions

What product was recalled? ▼
Douglas Labs Stress-B-Plus Dietary Supplement, Tablets, 90 tablets per bottle. UPC # 10539 97452, Lot Numbers ,50335944 and 50344396. Expiration Date 04/11/2026. Recalled by Nestle Product Technology Center - Nestle Health Science. Units affected: 3,269 bottles in market.
Why was this product recalled? ▼
Nestle Health Science (NHS U.S., LLC) is initiating a recall of Douglas Labs Stress-B-Plus Dietary Supplement Tablets, 90 tablets per bottle. The bottle is white and made of plastic. Lot Numbers 50335944,50344396, expiration date 04/11/2026. The product is being recalled because of Incorrect formulation manufactured vs label claims. Product was manufactured with Niacin (as Nicotinic acid) and supplement facts panel states contains Niacin (as Niacinamide).
Which agency issued this recall? ▼
This recall was issued by the FDA Food on November 27, 2024. Severity: Moderate. Recall number: F-0139-2025.

Related Recalls

FDA Drug Moderate

Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: U…

Unichem Pharmaceuticals USA Inc. · 2026-02-11
FDA Drug Critical

Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLumber.com, 2618 San…

Green Lumber Holdings, LLC · 2026-02-11
FDA Drug Moderate

Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500…

Granules Pharmaceuticals Inc. · 2026-02-11
FDA Drug Critical

Diclofenac Sodium, Topical Gel, 3%, 100 g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1…

SUN PHARMACEUTICAL INDUSTRIES INC · 2026-02-11
FDA Drug Critical

Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313

HANDELNINE GLOBAL LLC · 2026-02-11

Explore Related Data

Vehicle Safety → Drug Information →